Grants and Contributions:
Title:
Evaluation of Bio-Based Nanocarriers for Application in Drug Delivery Platforms
Agreement Number:
1006877
Agreement Value:
$74,795.00
Agreement Date:
Jun 1, 2023 - Apr 30, 2024
Description:
The bio-based nanocarriers produced with Pividl's patent pending technology will be investigated as multidrug and bioactive novel delivery systems. Formation mechanism, stability, encapsulation efficiency and other wet lab studies will enable us to determine which nanocarrier candidate will be selected for advancement and commercialization.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Moncton, New Brunswick, CA E1C 4X7
Reference Number:
172-2023-2024-Q1-1006877
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
730916079
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 43,835 dollars.
Amendment Date
Jul 7, 2023
Recipient's Operating Name:
Pividl Bioscience Inc.
Recipient's Legal Name:
Pividl Bioscience Inc.
Federal Riding Name:
Moncton--Riverview--Dieppe
Federal Riding Number:
13007
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
33149
Amendments: